These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34848465)

  • 1. Differences in Transport Characteristics and Cytotoxicity of Epirubicin and Doxorubicin in HepG2 and A549 Cells.
    Nagai K; Fukuno S; Shiota M; Tamura M; Yabumoto S; Konishi H
    Anticancer Res; 2021 Dec; 41(12):6105-6112. PubMed ID: 34848465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aclarubicin in subtoxic doses reduces doxorubicin cytotoxicity in human non-small cell lung adenocarcinoma (A549) and human hepatocellular carcinoma (HepG2) cells by decreasing DNA damage.
    Gajek A; Rogalska A; Koceva-Chyła A
    Toxicol In Vitro; 2019 Mar; 55():140-150. PubMed ID: 30579959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopic and cytotoxicity studies on the combined interaction of (-)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin.
    Guo Q; Liu M; Zhao Y; Wu Y; Liu J; Cai C; Shi Y; Han J
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117213. PubMed ID: 31177010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cytotoxicity in doxorubicin-exposed HepG2 cells pretreated with menthol due to upregulation of P-glycoprotein.
    Nagai K; Fukuno S; Miura T; Uchino Y; Sehara N; Konishi H
    Pharmazie; 2020 Oct; 75(10):510-511. PubMed ID: 33305727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of multi-drug resistance to anticancer drugs in HepG2 cells due to MRP2 upregulation on exposure to menthol.
    Nagai K; Tamura M; Murayama R; Fukuno S; Ito T; Konishi H
    PLoS One; 2023; 18(9):e0291822. PubMed ID: 37733713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
    Wang C; Wei X; Shao G
    Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Small interfering RNA targeting STAT3 enhances antitumor activity of doxorubicin].
    Wang TX; Wang YY; Zhang ZQ
    Yao Xue Xue Bao; 2013 Jan; 48(1):52-8. PubMed ID: 23600141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma.
    Ji YB; Ling N; Zhou XJ; Mao YX; Li WL; Chen N
    Asian Pac J Cancer Prev; 2014; 15(8):3651-7. PubMed ID: 24870773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced in vitro cytotoxicity of idarubicin compared to epirubicin and doxorubicin in rat prostate carcinoma cells.
    Siegsmund MJ; Stendler A; Kreukler C; Köhrmann KU; Alken P
    Eur Urol; 1997; 31(3):365-70. PubMed ID: 9129933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can marine-derived fungus Neosartorya siamensis KUFA 0017 extract and its secondary metabolites enhance antitumor activity of doxorubicin? An in vitro survey unveils interactions against lung cancer cells.
    Ramos AA; Castro-Carvalho B; Prata-Sena M; Malhão F; Buttachon S; Dethoup T; Kijjoa A; Rocha E
    Environ Toxicol; 2020 Apr; 35(4):507-517. PubMed ID: 31804023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells.
    Komori Y; Arisawa S; Takai M; Yokoyama K; Honda M; Hayashi K; Ishigami M; Katano Y; Goto H; Ueyama J; Ishikawa T; Wakusawa S
    Eur J Pharmacol; 2014 Feb; 724():161-7. PubMed ID: 24370495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
    Lo YL; Liu Y; Tsai JC
    Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma.
    Zhou X; Zhang M; Yung B; Li H; Zhou C; Lee LJ; Lee RJ
    Int J Nanomedicine; 2012; 7():5465-74. PubMed ID: 23093902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone increases epirubicin's apoptotic effects in HepG2 cells by S phase cell cycle arrest.
    Chang WT; Lin HL; Chang KL; Ker CG; Huang MC; Chen JS; Kuo KK; Chen YL; Lee KT
    Hepatogastroenterology; 2010; 57(97):107-13. PubMed ID: 20422883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pH-sensitive DNA tetrahedron for targeted release of anthracyclines: Binding properties investigation and cytotoxicity evaluation.
    Weng T; Wang L; Zhang X; Wu Y; Zhao Y; Zhang Y; Han J; Liu M
    Int J Biol Macromol; 2022 Dec; 223(Pt A):766-778. PubMed ID: 36372106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased proapoptotic activity of electron beam irradiated doxorubicin and epirubicin in multidrug-resistant human leukemic cells.
    Paszel-Jaworska A; Totoń E; Dettlaff K; Kaczmarek A; Bednarski W; Oszczapowicz I; Jelińska A; Rybczyńska M
    Chem Biol Interact; 2016 Oct; 258():69-78. PubMed ID: 27545834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a new pH-sensitive folate-doxorubicin conjugate and its antitumor activity in vitro.
    Ye WL; Teng ZH; Liu DZ; Cui H; Liu M; Cheng Y; Yang TH; Mei QB; Zhou SY
    J Pharm Sci; 2013 Feb; 102(2):530-40. PubMed ID: 23169439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.